Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinjiang Xinziyuan Pharmaceutical is a Chinese pharmaceutical company specializing in the extraction and processing of natural medicinal resources, particularly those derived from licorice (Glycyrrhiza). Based in the Xinjiang Uygur Autonomous Region, the company leverages the local abundance of high-quality licorice to produce active pharmaceutical ingredients (APIs) and finished dosage forms. Its core product portfolio includes glycyrrhizic acid derivatives, which are widely used for their anti-inflammatory and hepatoprotective properties. The company operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to serve both domestic and international markets. Xinjiang Xinziyuan Pharmaceutical plays a significant role in the industrialization of traditional Chinese medicine resources through advanced extraction technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinjiang Xinziyuan Pharmaceutical.